IGF1R (960-end), actif, son humain étiqueté, PRECISIO Kinase, recombinant, exprimé en cellules baculovirus infectées par Sf9 ,>=70% (SDS - PAGE), solution de glycérol aqueuse tamponnée

Code: i0786-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

IGF1R (insulin-like growth factor 1 receptor) is a transmembrane tyrosine kinase receptor that is activated by IGF1 (insulin-like growth factor 1) as ...


en savoir plus

Votre prix
£455.00 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

IGF1R (insulin-like growth factor 1 receptor) is a transmembrane tyrosine kinase receptor that is activated by IGF1 (insulin-like growth factor 1) as well as IGF2. IGF1R plays a key role in tumorigenesis. The IGF1R is implicated in several cancers, most notably breast cancer where it is highly overexpressed and causes disease progression and poor prognosis. In many instances, IGF1R overexpression allows cancerous cells to resist the cytotoxic properties of chemotheraputic drugs or radiotherapy.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50 mM Sodium Phosphate, pH 7.0, with 150 mM imidazole, 0.1 mM PMSF, 0.2 mM DTT, and 25% glycerol.

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... IGF1R(3480)
mol wt~53 kDa
product linePRECISIO® Kinase
Quality Level200
recombinantexpressed in baculovirus infected Sf9 cells
relevant disease(s)cancer
shipped indry ice
specific activity224-302 nmol/min·mg
storage temp.−70°C
UniProt accession no.P08069
Ce produit répond aux critères suivants: